Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, Sérgio Pinto de Souza et al.|Biomedicine & Pharmacotherapy|2021Cited by 121
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trialMarcelo Augusto Duarte Silveira, David De Jong, Erica Batista dos Santos Galvão et al.|medRxiv|2021Cited by 14
Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, Matheus de Alencar Menezes et al.|Scientific Reports|2023Cited by 8
The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, Sérgio Pinto de Souza et al.|Trials|2022Cited by 5
The Use of Standardized Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2): A Structured Summary of a Study Protocol for a Randomized Controlled TrialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, Sérgio Pinto de Souza et al.|Research Square|2021Cited by 0